- Home
- LGCL vs AVTX Comparison
LGCL vs AVTX Comparison
Compare LGCL & AVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LGCL
- AVTX
- Stock Information
- Founded
- LGCL 2009
- AVTX 2011
- Country
- LGCL China
- AVTX United States
- Employees
- LGCL N/A
- AVTX N/A
- Industry
- LGCL
- AVTX Biotechnology: Pharmaceutical Preparations
- Sector
- LGCL
- AVTX Health Care
- Exchange
- LGCL NYSE
- AVTX Nasdaq
- Market Cap
- LGCL 101.0M
- AVTX 90.9M
- IPO Year
- LGCL 2024
- AVTX 2015
- Fundamental
- Price
- LGCL $1.00
- AVTX $10.90
- Analyst Decision
- LGCL
- AVTX Buy
- Analyst Count
- LGCL 0
- AVTX 2
- Target Price
- LGCL N/A
- AVTX $35.00
- AVG Volume (30 Days)
- LGCL 160.5K
- AVTX 68.1K
- Earning Date
- LGCL 11-22-2024
- AVTX 11-07-2024
- Dividend Yield
- LGCL N/A
- AVTX N/A
- EPS Growth
- LGCL 11.49
- AVTX N/A
- EPS
- LGCL 0.14
- AVTX N/A
- Revenue
- LGCL $173,306,912.00
- AVTX $820,000.00
- Revenue This Year
- LGCL N/A
- AVTX N/A
- Revenue Next Year
- LGCL N/A
- AVTX N/A
- P/E Ratio
- LGCL $7.57
- AVTX N/A
- Revenue Growth
- LGCL N/A
- AVTX N/A
- 52 Week Low
- LGCL $0.96
- AVTX $3.95
- 52 Week High
- LGCL $5.00
- AVTX $34.46
- Technical
- Relative Strength Index (RSI)
- LGCL N/A
- AVTX 40.20
- Support Level
- LGCL N/A
- AVTX $12.00
- Resistance Level
- LGCL N/A
- AVTX $13.59
- Average True Range (ATR)
- LGCL 0.00
- AVTX 0.88
- MACD
- LGCL 0.00
- AVTX -0.40
- Stochastic Oscillator
- LGCL 0.00
- AVTX 16.67
About LGCL LUCAS GC LIMITED
Lucas GC Ltd is a technology-driven online agent-centric human capital management service provider targeting professionals based on PaaS in China.
About AVTX Avalo Therapeutics Inc.
Avalo Therapeutics Inc is a clinical stage biotechnology company focused on the treatment of immune dysregulation. The company's lead asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).